Home > Insider Trading > Filing (0001179110-11-007785)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1107421	Ziopharm Oncology Inc	ZIOP	Services-Specialty Outpatient Facilities, Nec (8093)	841475642

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1338535	Murray Brennan	Memorial Sloan Kettering Cancer Center 1275 York Avenue New York NY 10021		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $.001 Par Value	Disposition	2011-05-09	15,000	$6.57	52,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock, $.001 Par Value	Director Stock Option	$4.31	2006-12-22	2014-12-22	15,029	15,029	Direct
Common Stock	Stock Option (right to buy)	$5.01	2006-04-26	2016-04-26	15,000	15,000	Direct
Common Stock	Stock Option (right to buy)	$6.49	2009-12-13	2016-12-13	15,000	15,000	Direct
Common Stock	Stock Option (right to buy)	$4.85		2017-06-18	15,000	15,000	Direct
Common Stock	Stock Option (right to buy)	$2.73		2017-12-12	20,000	20,000	Direct
Common Stock	Stock Option (right to buy)	$0.70		2019-05-13	15,000	15,000	Direct
Common Stock, $.001 Par Value	Stock Option (right to buy)	$2.85		2019-12-31	7,500	7,500	Direct
Common Stock, $.001 Par Value	Stock Option (right to buy)	$5.09	2011-03-31	2020-03-31	15,000	15,000	Direct
Common Stock	Stock Option (right to buy)	$4.77		2020-12-31	30,000	30,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2014-12-22	15,029	15,029	Direct
2016-04-26	15,000	15,000	Direct
2016-12-13	15,000	15,000	Direct
2017-06-18	15,000	15,000	Direct
2017-12-12	20,000	20,000	Direct
2019-05-13	15,000	15,000	Direct
2019-12-31	7,500	7,500	Direct
2020-03-31	15,000	15,000	Direct
2020-12-31	30,000	30,000	Direct

Footnotes

Proceeds from the sales reported on this form were used to offset the reporting person's payment of tax obligations triggered by the vesting of previously awarded restricted stock. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.55 to $6.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
5,000 shares vest on each of 6/18/08, 6/18/09 and 6/18/10.
6,667 shares vest on each of 12/12/08 and 12/12/09; 6,666 shares vest on 12/12/10.
5,000 shares vest on each of 12/31/09, 6/30/10 and 12/31/10.
3,750 shares vest on each of 12/31/2010 and 12/31/2011.
10,000 shares vest on each of 12/31/2011, 12/31/2012 and 12/31/2013.
Includes grants of restricted stock with restrictions that lapsed as to 3,750 shares on December 31, 2010 and as to 15,000 shares on March 31, 2011; and restrictions that will lapse as to 3,750 shares on December 31, 2011.